RxDoctor Payments Data

Stacie Grossfeld, MD

Orthopedic Surgery · Louisville, KYNPI 1710980842

Payments from drug & device makers

$1,498in general payments, 2019–2025

Across 100 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$619
  • Smith+Nephew$193
  • Stryker$164
  • Johnson & Johnson$91
  • Pfizer$89
  • Blue Surgical LLC$49
  • plus $294 from 11 others

What the payments were for

  • Food & beverage$1,498100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)67$619
Smith+Nephew4$193
Stryker2$164
Johnson & Johnson4$91
Pfizer6$89
Blue Surgical LLC2$49
Acumed LLC1$46
Pacira Pharmaceuticals Incorporated2$46
Pacira Therapeutics, Inc.2$44
Zyla Life Sciences, Inc.3$39
Vericel Corporation1$25
BREG, Inc1$18
Boston Scientific1$16
Bioventus LLC1$16
Zimmer Biomet1$15
Avanos Medical1$14
Fidia Pharma USA Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopedic surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$206,393
Medicare patients
302
Services billed
3,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone148$779
Meloxicam79$518
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$242
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$82
Promethazine Hcl25$77
Tramadol Hcl22$32

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Louisville

Where these figures come from

Is this you, or does something look wrong? →